Norm- and hypo-fractionated radiotherapy is capable of activating human dendritic cells

References

• Abbas, A. K., Murphy, K. M., and Sher, A. 1996. Functional diversity of helper T-lymphocytes. Nature 383:787–793
   PubMed Web of Science ®Google Scholar
• Apetoh, L., Locher, C., Ghiringhelli, F., et al. 2011. Harnessing dendritic cells in cancer. Semin. Immunol. 23:42–49
   Google Scholar
• Banchereau, J., and Steinman, R. M. 1998. Dendritic cells and the control of immunity. Nature 392:245–252
   PubMed Web of Science ®Google Scholar
• Barcellos-Hoff, M. H., Derynck, R., Tsang, L. S., and Weatherbee, J. A. 1994. Transforming growth factor-β activation in irradiated murine mammary gland. J. Clin. Invest. 93:892–899
   PubMed Web of Science ®Google Scholar
• Birkholz, K., Schwenkert, M., Kellner, C., et al. 2010. Targeting of DEC-205 on human dendritic cells results in efficient MHC Class II-restricted antigen presentation. Blood 116:2277–2285
   PubMed Web of Science ®Google Scholar
• Burnette, B. C., Liang, H., Lee, Y., et al. 2011. The efficacy of radiotherapy relies upon induction of Type I IFN-dependent innate and adaptive immunity. Cancer Res. 71:2488i–2496
   Web of Science ®Google Scholar
• Dewan, M. Z., Galloway, A. E., Kawashima, N., et al. 2009. Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody. Clin. Cancer Res. 15:5379–5388
   PubMed Web of Science ®Google Scholar
• Driesen, J., Popov, A., and Schultze, J. L. 2008. CD25 as an immune regulatory molecule expressed on myeloid dendritic cells. Immunobiology 213:849–858
   PubMed Web of Science ®Google Scholar
• Ekong, U. D., Miller, S. D., and O’Gorman, M. R. 2009. In vitro assays of allo-sensitization. Pediatr. Transplant. 13:25–34
   PubMed Web of Science ®Google Scholar
• Formenti, S. C., and Demaria, S. 2009. Systemic effects of local radiotherapy. Lancet Oncol. 10:718–726
   PubMed Web of Science ®Google Scholar
• Formenti, S. C., and Demaria, S. 2013. Combining radiotherapy and cancer immunotherapy: A paradigm shift. J. Natl. Cancer Inst. 105:256–265
   PubMed Web of Science ®Google Scholar
• Frey, B., Stache, C., Rubner, Y., et al. 2012. Combined treatment of human colorectal tumor cell lines with chemotherapeutic agents and ionizing irradiation can in vitro induce tumor cell death forms with immunogenic potential. J. Immunotoxicol. 9:301–313
   Web of Science ®Google Scholar
• Garnett, C. T., Palena, C., Chakarborty, M., et al. 2004. Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T-lymphocytes. Cancer Res. 64:7985–7994
   PubMed Web of Science ®Google Scholar
• Gupta, A., Probst, H. C., Vuong, V., et al. 2012. Radiotherapy promotes tumor-specific effector CD8+ T-cells via dendritic cell activation. J. Immunol. 189:558–566
   PubMed Web of Science ®Google Scholar
• Hargadon, K. M. 2013. Tumor-altered dendritic cell function: Implications for anti-tumor immunity. Front. Immunol. 4:1–13
   PubMed Web of Science ®Google Scholar
• Hatfield, P., Merrick, A., Harringtony, K., et al. 2005. Radiation-induced cell death and dendritic cells: Potential for cancer Immunotherapy? Clin. Oncol. 17:1–11
   PubMed Web of Science ®Google Scholar
• Kalinski, P., Hilkens, C. M., Snijders, A., et al. 1997. IL-12-deficient dendritic cells, generated in the presence of prostaglandin E2, promote type 2 cytokine production in maturing human naive T-helper cells. J. Immunol. 159:28–35
   PubMed Web of Science ®Google Scholar
• Kim, K. H., Coi, J. S., Kim, I. J., et al. 2006. Promoter hypo-methylation and reactivation of MAGE-A1 and MAGE-A3 genes in colorectal cancer cell lines and cancer tissues. World J. Gastroenterol. 12:5651–5657
   PubMed Web of Science ®Google Scholar
• Ko, E. C., Forsythe, K., Buckstein, M., et al. 2011. Radiobiological rationale and clinical implications of hypo-fractionated radiation therapy. Cancer Radiother. 15:221–229
   PubMed Web of Science ®Google Scholar
• Lee, Y., Auh, S. L., Wang, Y., et al. 2009. Therapeutic effects of ablative radiation on local tumor require CD8+ T-cells: Changing strategies for cancer treatment. Blood 114:589–595
   PubMed Web of Science ®Google Scholar
• Lippitz, B. E. 2013. Cytokine patterns in patients with cancer: A systematic review. Lancet Oncol. 14:e218–e228
   PubMed Web of Science ®Google Scholar
• Lugade, A. A., Moran, J. P., Gerber, S. A., et al. 2005. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. J. Immunol. 174:7516–7523
   PubMed Web of Science ®Google Scholar
• Mantel, F., Frey, B., Haslinger, S., et al. 2010. Combination of ionizing irradiation and hyperthermia activates programmed apoptotic and necrotic cell death pathways in human colorectal carcinoma cells. Strahlenther. Onkol. 186:587–599
   PubMed Web of Science ®Google Scholar
• Mellman, I., and Steinman, R. M. 2001. Dendritic cells: Specialized and regulated antigen- processing machines. Cell 106:255–258
   PubMed Web of Science ®Google Scholar
• Morgan, E., Varro, R., Sepulveda, H., et al. 2004. Cytometric bead array: A multiplexed assay platform with applications in various areas of biology. Clin. Immunol. 110:252–266
   PubMed Web of Science ®Google Scholar
• Postow, M. A., Callahn, M. K., Barker, C. A., et al. 2012. Immunologic correlates of the abscopal effect in a patient with melanoma. New Engl. J. Med. 366:925–931
   PubMed Web of Science ®Google Scholar
• Reits, E. A., Hodge, J. W., Herberts, C. A., et al. 2006. Radiation modulates the peptide repertoire, enhances MHC Class I expression, and induces successful anti-tumor immunotherapy. J. Exp. Med. 203:1259–1271
   PubMed Web of Science ®Google Scholar
• Rubner, Y., Wunderlich, R., Rühle, P. F., et al. 2012. How does ionizing irradiation contribute to the induction of anti-tumor immunity? Front. Oncol. 2:1–11
   Google Scholar
• Rutkowski, M. R., Stephen, T. L., and Conejo-Garcia, J. R. 2012. Anti-tumor immunity: Myeloid leukocytes control the immune landscape. Cell. Immunol. 278:21–26
   Google Scholar
• Schaft, N., Dörrie, J., Müller, I., et al. 2006. A new way to generate cytolytic tumor-specific T-cells: Electroporation of RNA coding for a T-cell receptor into T-lymphocytes. Cancer Immunol. Immunother. 55:1132–1141
   PubMed Web of Science ®Google Scholar
• Schaft, N., Dörrie, J., Thumann, P., et al. 2005. Generation of an optimized polyvalent monocyte-derived dendritic cell vaccine by transfecting defined RNAs after rather than before maturation. J. Immunol. 174:3087–3097
   PubMed Web of Science ®Google Scholar
• Schildkopf, P., Frey, B., Ott, O. J., et al. 2011. Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages. Radiother. Oncol. 101:109–115
   PubMed Web of Science ®Google Scholar
• Tsai, M. H., Cook, J. A., Chandramouli, G. V. R, et al. 2007. Gene expression profiling of breast, prostate, and glioma cells following single vs. fractionated doses of radiation. Cancer Res. 67:3845–3852
   PubMed Web of Science ®Google Scholar
• Velten, F. W., Rambow, F., Metharom, P., and Goerdt, S. 2007. Enhanced T-cell activation and T-cell-dependent IL-2 production by CD83+, CD25high, CD43high human monocyte-derived dendritic cells. Mol. Immunol. 44:1544–1550
   PubMed Web of Science ®Google Scholar
• Wolden, S. L., Rabinovitch, R. A., Bittner, N. H., et al. 2013. American College of Radiology (ACR) and American Society for Radiation Oncology (ASTRO) Practice Guideline for the Performance of Total Body Irradiation (TBI). Am. J. Clin. Oncol. 36:97–101
   PubMed Web of Science ®Google Scholar
• Wuest, S. C., Edwan, J. H., Martin, J. F., et al. 2011. A role for O:-2 trans-presentation in dendritic cell-mediated T-cell activation in humans, as revealed by daclizumab therapy. Nat. Med. 17:604–609
   PubMed Web of Science ®Google Scholar